Journal of Gynecologic Oncology (JGO)

In this episode, we discuss a phase II study by Chen Li and colleagues that evaluates the efficacy and safety of toripalimab, a PD-1 inhibitor, combined with bevacizumab and platinum-based chemotherap...

31 Joulu 20244min

In this episode of the Journal of Gynecologic Oncology podcast, we discuss a study by Natsuki Osawa and colleagues titled "Oncological safety of minimally invasive surgery in borderline ovarian tumor ...

24 Joulu 20244min

In this episode, we review the multi-center study led by Zhong and colleagues, which investigates the efficacy of combining bevacizumab with chemotherapy in relapsed ovarian cancer after prior PARP in...

17 Joulu 20245min

In this episode, we delve into the NIVEC study, a phase 2 trial investigating the use of nivolumab, a programmed cell death protein 1 inhibitor, as a neoadjuvant therapy for patients with mismatch rep...

11 Joulu 20244min

In this episode, we discuss an exciting study by Okazawa-Sakai and colleagues from Japan, titled "Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer." This research...

26 Marras 20245min

This episode explores a study led by Dr. Shuai Huang from Beijing Hospital, examining the efficacy and safety of combining anlotinib, a multi-target tyrosine kinase inhibitor, with oral etoposide for ...

19 Marras 20245min

In this episode, we explore a new study on pembrolizumab’s effectiveness in microsatellite instability-high endometrial cancer, focusing on three subtypes: sporadic (MLH1 hypermethylated), Lynch-like ...

12 Marras 20247min

In this episode, we introduce the REMPA trial, a study from the Japanese Gynecologic Oncology Group evaluating the safety and efficacy of Repeated Medroxyprogesterone Acetate therapy for young patient...

5 Marras 20245min